Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
Swapleber
Posted in: ORPH.L
Posts: 1,247
note out last week with a 28p target when the share was 30??
super endorsement!
And it’s getting way to salty.
And it will go down further
The data side is probably worth hundreds of millions. He may expand a little tomorrow evening
Reminding those who took pleasure in Biondvax’s failure, not to be so damn clever. IMHO
Tomorrow is a new day!!!
Constant need to test new vaccines via challenge studies. Simples.
Buy lottery tickets instead then
Had a price of 8 pence on April 26(I’m sure it was lower just befor this..but let’s take 8 p)It’s now worth over 24 pWho is complaining about this and why?I certainly not...Get a grip.
I ain’t selling anytime soon, so I’ll just have to weather the odd bit of choppiness
News tomorrow Because the man on the top floor of the Clapham Omnibus don’t av’ a clue.
Yeah but, it magnifies the high risk nature of the project.
Cher nob yl drop off
Adds zero to imutex’s fluv chance of success
Nanoflu reads as a seasonal vaccine here. Maybe that’s why??https://www.pharmaceutical-technology.com/news/novavax-nanoflu-influenza/
Seek is not a subsidiary of hVivoHvivo owns 49% of Seek group who have flu v.
https://twitter.com/eskers1/status/1320076820151209986?s=21
That’s a sooooper dooooper article moniman....well spotted.
I’m hoping relatively cheaply is 500 m
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE